“…This study extends previous work by clarifying the conditional effects of chronic pain, rural residence, and unmet treatment need on risk for cannabis use (Eaton et al, 2018;Park & Wu, 2017). The use of medical cannabis for chronic pain treatment often fails to align with actual medical guidelines or be administered by medical healthcare professionals, resulting in unintended overdose or poisoning, higher risk consumption modalities (e.g., smoking, vaping), higher rates of co-use with prescription opioids (34% in this sample), and greater negative adverse events (e.g., car accidents, falls) (Azizoddin et al, 2023;Busse et al, 2021). Additionally, in Oklahoma, a recent assessment found that 55% of patients with an MCL still obtain at least some of their cannabis from illicit sources (Mudd et al, 2023), which can place them at a higher risk for using contaminated supply (e.g., contains pesticides or microorganisms), using more than intended due to mislabeling, or legal issues (Boehnke et al, 2020;MacCallum et al, 2023).…”